Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Sean Salmon, who leads the company’s cardiovascular group, said cryoablation procedures draw the company less revenue per case than PFA procedures. Medtronic’s adjusted net profit rose to $1. ...

Medtronic stock slumped Tuesday despite beating ... heart rhythm — had "strong growth," helping offset declines in cryoablation. Cryoablation uses extreme cold to destroy abnormal tissue.

Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will ...

Medtronic introduced a next-generation cryoablation system designed for enhanced tumor targeting and patient outcomes. Statistical Insights .Approximately 20 million new cancer cases were reported ...